Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Catheter Precision, Inc. Director's Dealing 2024

Jan 18, 2024

35479_dirs_2024-01-18_cac019af-9da6-49af-b4dc-eecffab62074.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Catheter Precision, Inc. (VTAK)
CIK: 0001716621
Period of Report: 2024-01-16

Reporting Person: JENKINS DAVID A (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-01-16 Common Stock P 7793 $0.3862 Acquired 285390 Direct
2024-01-16 Common Stock P 8470 $0.3912 Acquired 293860 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 709703 Indirect
Common Stock 2264 Indirect
Common Stock 2264 Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging
from $00.3820 to $00.3923, inclusive on January 16, 2024 and $00.3898 to $00.3968, inclusive on January 17, 2024. The reporting
person undertakes to provide Catheter Precision, Inc., any security holder of Catheter Precision, Inc., or the staff of the Securities and
Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the
ranges set forth above.

F2: Shares held by a partnership of which the reporting person is the managing member of the managing partner.

F3: Shares held by by charitable remainder unitrust of which reporting person's spouse is the trustee.

F4: Shares held by private foundation of which reporting person is the trustee